Focus on Bipolar Disorder: 6 New Studies

Slideshow

Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.

Related Videos
journey
Related Content
From a groundbreaking FDA approval to the hidden toll of COVID-19, here are highlights from the week in Psychiatric Times.

The Week in Review: April 1-5

April 6th 2024
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

August 4th 2021
Podcast
Our Mood Disorders Section Editor discusses the disorder in honor of World Bipolar Day.

An Update on Bipolar I Disorder

March 30th 2024
Article
Four Myths About Lamotrigine

Four Myths About Lamotrigine

August 3rd 2021
Podcast
Here’s a look back at selections from our March content series on mood disorders.

Recap: Mood Disorders 2024

March 29th 2024
Article
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.

Evidence-Based Novel Therapies for Bipolar Depression: Top 5 Takeaways

March 26th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.